Jan 15 (Reuters) - Pfizer (PFE.N), opens new tab will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon (HLN.L), opens new tab, lowering its stake in the British consumer healthcare ...
Pfizer PFE0.84%increase; green up pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN 0.74%increase; green up pointing triangle for 2.50 billion pounds ...
Pfizer (PFE) announces that it intends to sell approximately 700M ordinary shares in Haleon plc (HLN), representing approximately 7.7% of Haleon’s issued share capital. “There will be no sale ...
The UK pharma group – now a therapeutics and vaccines pure-play since the spin-off of Haleon in July – also raised its financial forecasts for the full year for the second time in consecutive ...
(RTTNews) - Pfizer Inc. (PFE) Wednesday announced the sale of 700 million shares in Haleon Plc (HLN), a British multinational consumer healthcare company, at 357 pence per share or approximately $ ...
Hosted on MSN1mon
US Soccer and Haleon announce new multi-year partnershipThe US Soccer governing body and international health firm Haleon have announced a new multi-year partnership. As part of the tie-up, Haleon, the parent company of brands such as Advil ...
Pfizer plans to cut its stake in Haleon through an accelerated bookbuilding process to institutional investor, starting immediately. The New York drugmaker said Tuesday that the proposed sale ...
Haleon hit the streets of New York on Wednesday to encourage folks to shop for their favorite health products — with a twist. The consumer health company that oversees brands like Advil, Tums and ...
Pfizer has sold 700 million shares in British consumer-healthcare business Haleon for 2.50 billion pounds, equivalent to US$3.05 billion, it said in a statement. The U.S. drugmaker said Wednesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback